Stock Expert AI

EFG (EFG) ETF Analysis

EFG is an ETF providing exposure to a concentrated portfolio of 10 European and Asian companies. Its top holdings include ASML Holding NV, AstraZeneca PLC and Novartis AG Registered Shares. With a dividend yield of 2.34% and a beta of 1.09, EFG offers a blend of income and market sensitivity. Investors should note the concentrated nature of the fund, which may lead to higher volatility compared to more diversified ETFs. Past performance does not guarantee future results.

EFG (EFG) ETF — Price, Holdings & Analysis

EFG is an ETF providing exposure to a concentrated portfolio of 10 European and Asian companies. Its top holdings include ASML Holding NV, AstraZeneca PLC and Novartis AG Registered Shares. With a dividend yield of 2.34% and a beta of 1.09, EFG offers a blend of income and market sensitivity. Investors should note the concentrated nature of the fund, which may lead to higher volatility compared to more diversified ETFs. Past performance does not guarantee future results.

ETF Overview

EFG aims to provide investors with targeted exposure to a select group of established international companies. Unlike broad market ETFs, EFG holds only 10 companies, creating a focused portfolio. The fund's strategy centers on identifying and holding companies with strong market positions and potential for long-term growth. The top holdings reflect a bias towards technology and healthcare, with ASML Holding NV, AstraZeneca PLC, and Novartis AG Registered Shares representing a significant portion of the fund. Other notable holdings include SAP SE and Schneider Electric SE. This concentrated approach differentiates EFG from more diversified ETFs, potentially leading to higher returns but also increased risk. Investors seeking targeted exposure to specific international companies may find EFG suitable, but should carefully consider the concentration risk. Past performance does not guarantee future results.

Risk Metrics

EFG's concentrated portfolio of only 10 holdings introduces significant concentration risk. A downturn in any of its top holdings, such as ASML Holding NV (5.28%), could disproportionately impact the fund's performance. The fund's beta of 1.09 indicates that it is slightly more volatile than the overall market. While the expense ratio is not provided, it will detract from overall returns. Investors should be aware that the lack of diversification in EFG can lead to greater price swings compared to broader market ETFs. The focus on specific sectors, such as technology and healthcare, also exposes the fund to sector-specific risks. Past performance does not guarantee future results.

Top Holdings

Dividend Yield

2.34%

Risk Metrics

  • Beta: 1.09

Questions & Answers

What is EFG and what does it track?

EFG is an ETF that provides exposure to a concentrated portfolio of 10 international companies. Unlike broad market ETFs, EFG focuses on a select group of holdings, primarily in Europe and Asia. The fund's top holdings include companies like ASML Holding NV, AstraZeneca PLC, and Novartis AG Registered Shares. This concentrated approach aims to deliver targeted exposure to specific companies, potentially leading to higher returns but also increased risk. Investors should carefully consider the concentration risk before investing. Past performance does not guarantee future results.

What is the expense ratio for EFG?

The expense ratio for EFG is not explicitly provided in the given data. However, it's important to consider the expense ratio as it directly impacts the overall return of the investment. Generally, a lower expense ratio is more favorable as it means less of the investment return is being used to cover the fund's operating costs. Investors should research the fund's official documentation to determine the exact expense ratio and compare it to similar ETFs in the same category.

What are the top holdings in EFG?

The top holdings in EFG include ASML Holding NV (5.28%), AstraZeneca PLC (3.03%), and Novartis AG Registered Shares (3.01%). These three companies represent a significant portion of the fund's total assets. Other notable holdings include SAP SE (1.97%) and Schneider Electric SE (1.67%). The concentration in these top holdings means that the fund's performance is heavily influenced by the performance of these individual companies. Investors should be aware of this concentration risk. Past performance does not guarantee future results.

Is EFG a good long-term investment?

Whether EFG is a suitable long-term investment depends on an investor's individual circumstances, risk tolerance, and investment goals. The fund's concentrated portfolio of 10 holdings introduces both opportunities and risks. The dividend yield of 2.34% may be attractive to income-seeking investors. However, the fund's beta of 1.09 indicates that it is slightly more volatile than the overall market. Investors should carefully consider these factors and their own investment objectives before making a decision. Past performance does not guarantee future results.

How does EFG compare to similar ETFs?

EFG distinguishes itself from similar ETFs through its highly concentrated portfolio of only 10 holdings. Many international equity ETFs offer broader diversification across a larger number of companies. While the expense ratio is not provided, this is a key factor to compare with other ETFs. EFG's strategy of focusing on a select group of companies may lead to higher potential returns, but also greater risk compared to more diversified ETFs. Investors should weigh the potential benefits and risks of this concentrated approach. Past performance does not guarantee future results.

Does EFG pay dividends?

Yes, EFG does pay dividends. The current dividend yield is 2.34%. This means that for every $100 invested in EFG, investors can expect to receive $2.34 in dividend payments annually, before any applicable taxes or fees. The dividend yield can fluctuate based on the fund's performance and the dividend policies of its underlying holdings. Investors seeking income may find EFG's dividend yield attractive. Past performance does not guarantee future results.